Posts in category Business Standard
Aurobindo Pharma receives USFDA final approval for Deflazacort Tablets (12-02-2024)
The product will be launched in February 2024. The approved product has an estimated market size of US$ 67 million for the three months ending September2023, according to PTC Therapeutics Inc. Aurobindo now has a total of 502 ANDA approvals (482 Final approvals and 20 tentative approvals) from USFDA.
Benchmarks end with substantial cuts; Hero MotoCorp drops over 4% (12-02-2024)
As per provisional closing data, the barometer index, the S&P BSE Sensex, tumbled 523 points or 0.73% to 71,072.49. The Nifty 50 index declined 166.45 points or 0.76% to 21,616.05.
EURUSD Stay Sluggishly Below $1.08 As DXY Regains Momentum Above 104 Mark (12-02-2024)
Euro slipped back below 1.08 mark against the greenback as dollar index regained momentum above 104 mark by European trading hours. EURUSD earlier in the day hit a high of $1.0821 and is currently quoting lower by 0.12% at $1.0785. Uncertainty over the likely timing and pace of interest rate cuts by the Federal Reserve (Fed) is keeping the dollar index on the defensive below a two and half month high touched last week. Meanwhile, large currency speculators net long positions in the Euro futures market dropped lower through February 06, 2024 and registered a weekly decline of 26618 net contracts taking net long position to its lowest level in over 15 months. On the NSE, EURINR was trading at 89.54, down marginally on the day.
Australia Market ends lower (12-02-2024)
At closing bell, the benchmark S&P/ASX200 index declined 29.92 points, or 0.39%, to 7,614.92. The broader All Ordinaries index dropped 24.35 points, or 0.31%, to 7,860.34.
Atmastco to launch IPO worth Rs 56 crore on Feb 15 at Rs 77 apiece (12-02-2024)
Engineering, procurement and construction firm Atmastco Ltd on Monday said it will raise a little over Rs 56 crore through an initial public offering that will open for subscription on February 15.
Post the completion of the Initial Public Offering (IPO), shares of the Bhilai- headquartered company will be listed on the National Stock Exchange's Small and Medium Enterprise (SME) platform -- NSE Emerge.
The company's IPO is a combination of fresh issue of 54.8 lakh equity and an Offer For Sale (OFS) of 18.25 lakh shares with a fixed price of Rs 77 apiece, according to a statement.
At this price, the company will mobilise Rs 42.2 crore through the fresh issue and Rs 14.06 crore by way of OFS.
Proceeds from the fresh issue will be primarily used for funding the working capital requirements of the company. Besides, some amount will be used for repayment of loans and general corporate purposes.
The maiden public issue opens for subscription on February 15 and will conclude on February
Former Maharashtra chief minister Ashok Chavan resigns from Congress (12-02-2024)
Chavan's resignation carries added weight due to his familys political legacy, as his father, Shankarrao Chavan, also held the position of Chief Minister of Maharashtra. With the culmination of Chavan's decades-long association with the party, Maharashtra's political landscape stands poised for potential shifts and realignments.
Bharat Forge slides after company expects moderate growth in Q4 (12-02-2024)
Bharat Forge tumbled 13.31% to Rs 1,139.95 after the company stated that it expects the growth momentum to moderate in both domestic & export market across industries in fourth quarter and in FY25.
Fermenta Biotech reports consolidated net profit of Rs 9.85 crore in the December 2023 quarter (12-02-2024)
Sales rise 80.40% to Rs 98.97 crore
Ami Organics consolidated net profit declines 24.82% in the December 2023 quarter (12-02-2024)
Sales rise 9.24% to Rs 166.44 crore
Force Motors reports consolidated net profit of Rs 85.40 crore in the December 2023 quarter (12-02-2024)
Sales rise 29.74% to Rs 1691.69 crore